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The pioneering proposals to use catheter procedures to treat 
congenital heart disease were published over 20 years ago 
(1-3). Only in the last half decade, however, have most of 
these procedures achieved sufficient clinical maturity to af-
fect the delivery of cardiac care to children. In some centers, 
such procedures now constitu~e a large percentage of all 
cardiac catheterizations performed (Fig. 1). 
During the last 5 years, various workers have laid the 
experimental foundations for most of these transcatheter 
techniques. Others have described the initial clinical ex-
periences for balloon angioplasty of pulmonary veins (4), 
pulmonary arteries (5), pulmonary valves (6), native (7) and 
recurrent (7,8) aortic coarctations, aortic valves (9) and 
obstructed intracardiac baffles (10). In addition to these 
balloon angioplasties and v;tlvuloplasties, other transcath-
eter techniques have been successfully applied to congenital 
heart disease, including knife atrial septostolllY (11), closure 
of the patent ductus arteriosus (12,13), closure of large 
systemic pulmonary artery vessels (14,15) and arteriovenous 
fistulas (16). As a group, these procedures are still too new 
to identify their indications and contraindications with any 
precision. Nonetheless, enough clinical experience has ac-
crued to allow a discussion of how these techniques appear 
to fit into the current practice of pediatric cardiology at our 
own institution. 
Procedures Currently Indicated 
Balloon Catheter Procedures 
Balloon atrial septostomy. This procedure, the first 
catheter intervention to prove useful in cardiac medicine 
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(2), remains the standard initial palliation in transposition 
of the great arteries. It is safe and very effective. 
Pulmonary valve stenosis. Balloon valvuloplasty for 
typical pulmonary stenosis outside the newborn period is a 
very safe procedure; several hundred have been performed 
in the past 2 years without a reported fatality or major morbid 
event. Initial reports (17,18) on the use of balloons less than 
the size of the anulus described gradient reductions of 50 
to 60%. Subsequent use of balloons 20 to 40% larger than 
the anulus have produced gradient reduction (70 to 75%) 
equivalent to that of surgery (19). Short-term (1 to 3 years) 
follow-up has indicated no significant incidence of reste-
nosis or important regurgitation. The initial notion that the 
severely dysplastic pulmonary valve generally cannot be 
dilated has, in our experience, held up; although it is rea-
sonable to attempt dilation in patients with such valves, 
most will require operative resection of valvular tissue, to-
gether with anular augmentation. Thus, we now consider 
balloon valvuloplasty the treatment of choice for typical 
valvular pulmonary stenosis. 
Recurrent postoperative aortic obstructions. Despite 
the ongoing advances in surgical management of aortic arch 
obstruction, the incidence of recurrent narrowing after repair 
in infancy of coarctation, interruption of the aortic arch and 
hypoplastic left heart syndrome remains 5 to 20%. Several 
centers have reported good results from reoperations with 
low mortality rates and gradient reductions approaching 70%. 
It is now clear that equivalent results can be achieved with 
balloon angioplasty (20). 
The major unresolved issue in these patients in that of 
late aneurysm. Neither postoperative nor postangioplasty 
patients have been studied carefully over a long period of 
time to ascertain the incidence of this complication. Despite 
the limited information now available, we consider angio-
plasty the treatment of choice in all such patients. 
Hypoplastic or stenotic pulmonary arteries. Balloon 
angioplasty of such lesions remains technically difficult, and 
there is a small (1 to 2%) but significant mortality rate 
associated with the procedure. Because operative manage-
ment of such lesions outside the mediastinum is unsuc-
cessful, angioplasty remains the only therapeutic option for 
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Figure 1. Therapeutic cardiac catheterizations at Children' s Hos-
pital, Boston. This increase in therapeutic catheterizatIOn, occurred 
with total case volumes ranging from 650 (in 1983) to 825 (Ill 
1985), representing an increased incidence of procedures from 1.5 
to 18%. 
most patients. Fifty percent of such lesions can be suc-
cessfully dilated (increasing the diameter of the narrowed 
artery by 50% or more) with higher success rates in patients 
less than 3 to 4 years of age. 
Any child with symptomatic right heart failure, cyanosis 
or suprasystemic right ventricular pressures due to pulmo-
nary artery stenosis should undergo balloon angioplasty, 
preferably in the first 3 to 4 years of life. Children with a 
near systemic right ventricular pressure or marked flow ab-
normalities (that is, < 15% of total cardiac output going to 
one lung) should certainly be considered for balloon angio-
plasty. It is clear that even minor degrees of pulmonary 
artery narrowing are poorly tolerated after the Fontan op-
eration; lesions that produce mean gradients as small as 3 
to 4 mm Hg after a Fontan procedure should probably be 
dilated in symptomatic children. 
Finally, balloon angioplasty may be very useful as part 
of the pulmonary vascular rehabilitation of patients with 
tetralogy of Fallot, pulmonary atresia and small pulmonary 
arteries. In such patients, we are attempting early estab-
lishment of central pulmonary artery flow from the right 
ventricle, followed by angioplasty of the residual narrow-
ings. 
Obstructed intracardiac baffles. Increasing use of the 
arterial switch operation and improved atrial techniques have 
made this complication of repaired transposition of the great 
arteries increasingly rare. When obstruction occurs, it ap-
pears to be at the level of the old interatrial septum. The 
use of very large balloons will enlarge the narrowed channel 
and decrease the gradient in almost every patient. Although 
late follow-up is not yet available, such patients can remain 
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symptom-free for 2 to 3 years. Thus, angioplasty should 
probably be considered as the initial treatment in such pa-
tients. 
Other Catheter-Directed Procedures 
In addition to balloon angioplasty catheter techniques, 
several other forms of catheter-directed therapy have be-
come standard practice in the past few years. 
Drainage of pericardial effusions. Accurate two-di-
mensional echocardiography has revolutionized the man-
agement of pericardial fluid in children (21). The localiza-
tion and quantification of the fluid around the heart has made 
percutaneous drainage an extremely safe procedure even in 
patients with poor hemodynamic status, localized fluid or a 
bleeding diathesis. Once the correct needle course has been 
identified and a guide wire positioned in the pericardial 
space, large bore (8F) catheters can be introduced over the 
wire for long-term effective drainage. Even in diagnostic 
pericardiocentesis, the most prudent course might be to in-
troduce a catheter and, once the nature of the fluid has been 
established, decide whether to remove the catheter or leave 
it in for long-term drainage. The only patients whose peri-
cardial fluid cannot be drained percutaneously are those 
whose fluid is inaccessible from a precordial, subxiphoid 
or subcostal approach or those whose pericardium needs to 
be removed. 
Obstruction of the interatrial septum. In patients with 
mitral atresia or stenosis and either an anatomic or a func-
tional single ventricle, wide patency of the interatrial septum 
is needed to allow unobstructed pulmonary venous drainage. 
Although surgical atrial septostomy or septectomy has been 
standard in these children, the use of the Park blade catheter 
followed by balloon septostomy has considerable advan-
tages; it has been proven to be safe, it can be repeated at 
low risk and its short-term efficacy has been good. Because 
the ultimate palliation for these children will be a Fontan 
type of operation, one needs to lower left atrial pressure to 
rather low levels (that is, <8 mm Hg). Once again, late 
follow-up is lacking for both surgical and catheter tech-
niques to open the atrial septum but. at present, the tran-
scatheter technique as the initial procedure appears to offer 
considerable advantages. 
Occlusion of redundant systemic pulmonary collat-
eral arteries. In patients with tetralogy of Fallot and pul-
monary atresia, or similar lesions, blood supply to the lungs 
frequently occurs through systemic pulmonary collateral ar-
teries (so-called bronchial arteries). These vessels frequently 
anastomose with true pulmonary arteries; after shunts into 
the pulmonary arteries, the lung may have a dual supply to 
the same capillary bed. At the time of complete repair, these 
(now redundant) systemic pulmonary collateral arteries need 
to be occluded: they will complicate intraoperative man-
agement by allowing pumped blood to reach the lungs during 
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cardiopulmonary bypass, and leave an unwanted left to right 
shunt in the postoperative period. Operative ligation of such 
vessels can be difficult, especially from an anterior approach 
at the time of complete repair. 
The use of either detachable balloons or preformed steel 
coils to occlude such vessels allows precise definition of the 
vascular anatomy at the time of occlusion and can be per-
formed with considerable safety and accuracy. Perhaps 75 
or 85% of collateral arteries have a long and straight enough 
course to allow transcatheter closure. 
Procedures Currently 
Considered Experimental 
Aortic valve stenosis. Surgical aortic valvotomy, out-
side of the newborn period, is a relatively safe procedure 
in pediatric patients, mortality rates are 1 to 2%, and fewer 
than 5% of such patients require valve replacement in the 
perioperative period because of iatrogenic aortic regurgi-
tation. However, the procedure is clearly not curative, pres-
sure gradient reductions are only 50 to 70%, restenosis is 
not uncommon and there is a distressingly high incidence 
of deaths in the decades after surgery (22). In that context, 
balloon angioplasty, albeit imperfect, offers several advan-
tages: it appears to provide roughly the same degree of 
pressure gradient reduction (at least over the short term) and 
can be repeated a number of times should valve restenosis 
occur. Because most of the patients develop at least some 
degree of valvular regurgitation (usually mild) in the post-
dilation period, and because the impact of balloon valvu-
loplasty on late gradients and late mortality remains unclear, 
it must still be viewed at this time as an unproved form of 
therapy. 
Patent ductus arteriosus. The surgical closure of the 
patent ductus arteriosus offers superb results at a very small 
mortality or morbidity rate. Using the double umbrella de-
vice developed by.Rashkind (12), there has been a promising 
start in several centers for transcatheter closure (success 
rates over 70% with no mortality and minimal morbidity). 
In patients who are at increased risk for thoracotomy for 
any of a number of reasons, transcatheter patent ductus 
arteriosus closure may well be indicated. However, because 
many patent ductus are closed to prevent bacterial arteritis, 
and because the impact of transcatheter closure on the late 
incidence of endocarditis is unknown, it will be some years 
before the ultimate role of this procedure becomes clear. 
In our opinion, this device may already be very useful 
to close large nonpatent ductus arteriosus openings else-
where in the vascular tree. In many such cases (very large 
systemic pulmonary collateral vessels, persistent left su-
perior vena cava to the left atrium and others) the surgical 
risks may be considerably higher than those for a simple 
patent ductus arteriosus ligation, thus making transcatheter 
closure a more attractive option. 
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Unoperated (native) aortic coarctations. Studies have 
now shown (23) that, after infancy, the native aortic coarc-
tation can be dilated with very good short-term gradient 
reduction and minimal morbidity. However, both animal 
and now some clinical trials (24) have demonstrated a sig-
nificant incidence of' 'aneurysm" formation, 6 to 12 months 
after the procedure, in the area of the old coarctation. Al-
though none of these lesions have produced symptoms, their 
angiographic appearance has prompted prophylactic exci-
sion of the affected area. At present, not all groups engaged 
in angioplasty of native coarctations have observed late an-
eurysms, and it is possible that some (as yet unidentified) 
variations in catheter technique or aortic arch anatomy may 
predispose to aneurysm formation. If so, such aneurysms 
may be avoidable. Given the good results of surgery for 
coarctation, this procedure must be viewed as experimental 
until more late follow-up data become available. 
Even with the potential risks of late aneurysm formation, 
there are occasional clinical circumstances in which standard 
operative management becomes a high risk procedure be-
cause of severe associated cardiac or noncardiac defects. In 
such cases, angioplasty can prove invaluable as an initial 
therapy to allow normalization of blood pressure and re-
duction of ventricular afterload. 
Conclusions 
Transcatheter therapy has substantively altered cardiac 
care for children in the past 5 years. Although no firm 
conclusions can be reached until more extensive follow-up 
is available, it appears that a number of procedures have 
already replaced operative management. Even the proce-
dures we currently consider experimental will undoubtedly 
play some role in the management of congenital cardiac 
disease. 
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